Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02270502 · ClinicalTrials.gov registry record
Effects of Frailty, Sarcopenia and Muscle Wasting on Outcomes of Patients in the Surgical Intensive Care Unit
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 111
- Enrollment target
NCT02270502: Completed study, sponsored by Massachusetts General Hospital.
NCT02270502 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 111 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02270502 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 111 participants
- Enrollment target
Study Summary
The primary aim of the study is to evaluate consequences of frailty in critically ill patients. We hypothesize that a higher frailty index (based on published questionnaires) predicts a longer surgical intensive care unit and hospital length of stay, less ventilator-free days and a higher likelihood of an adverse discharge disposition. Our secondary aim is to identify muscle-size derived variables that can be used to predict frailty. We hypothesize that a low skeletal muscle mass measured by ultrasound can be used to quantify frailty, and to also predict the outcome of SICU patients, expressed as longer stay in the surgical intensive care unit and longer stay in the hospital, less ventilator-free days and a higher likelihood of an adverse discharge disposition. Our third aim is to examine potential triggers of muscle wasting in critically ill patients. Muscle wasting will be assessed by repetitive ultrasound measurements of muscle mass. We hypothesize that a significant decrease in skeletal muscle mass predicts longer stay at the surgical intensive care unit and longer hospital length of stay, less ventilator-free days and adverse discharge disposition.
Interventions
- DEVICE Ultrasound Philips CX50
- OTHER Frailty Index Questionnaire
- OTHER Muscle strength tests
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2014-05 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02270502
The ClinicalTrials.gov registry entry for NCT02270502 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Ultrasound Philips CX50 is the first listed.
NCT02270502 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02270502 about?
NCT02270502 is a clinical study titled "Effects of Frailty, Sarcopenia and Muscle Wasting on Outcomes of Patients in the Surgical Intensive Care Unit". The primary aim of the study is to evaluate consequences of frailty in critically ill patients. We hypothesize that a higher frailty index (based on published questionnaires) predicts a longer surgical intensive care unit and hospital length of stay, less ventilator-free days and a higher likelihood...
What is the current status of trial NCT02270502?
This trial is currently completed. The enrollment target is 111 participants. The study started on 2014-05. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02270502?
The interventions under investigation include: Ultrasound Philips CX50 (DEVICE), Frailty Index Questionnaire (OTHER), Muscle strength tests (OTHER).
Who is sponsoring clinical trial NCT02270502?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.